AFT Pharmaceuticals (ASX:AFP) is a growing multinational pharmaceutical company that develops, markets, and distributes a broad portfolio of pharmaceutical products across a wide range of therapeutic categories. AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs. AFT Pharmaceuticals' operations are focused on the development, commercialisation, and distribution of its pharmaceutical products. The company has a team of experienced and knowledgeable staff who are able to work with healthcare professionals to ensure that patients have access to the medicines they need. AFT Pharmaceuticals' current projects include the development of new pharmaceutical products, the expansion of its international footprint, and the acquisition of new products and businesses. The company is also working on a number of initiatives to improve its manufacturing and supply chain capabilities.